Skip to main content
Top
Published in: Journal of Cancer Education 2/2016

01-06-2016

Factors Influencing Chemotherapy Goal Perception in Newly Diagnosed Cancer Patients

Authors: Ozge Gumusay, Bulent Cetin, Mustafa Benekli, Gamze Gurcan, Mustafa N. Ilhan, Basak Bostankolu, Ahmet Ozet, Aytug Uner, Ugur Coskun, Suleyman Buyukberber

Published in: Journal of Cancer Education | Issue 2/2016

Login to get access

Abstract

Cancer patients who start receiving chemotherapy have difficulty in understanding the state of their disease, the prognosis, and the purpose of treatment. We used a survey to evaluate the extent of perception of chemotherapy goal among cancer patients. Two hundred sixteen cancer patients who received chemotherapy for the first time participated in the study. The presence of depression and anxiety was assessed using the “Hospital Anxiety and Depression Scale” (HAD). The consistency between the patients’ perception of the chemotherapy goal and the physician’s perception was described as “right,” and the inconsistency was described as “wrong.” Among the patients who participated in the survey, 53.2 % (n = 115) were receiving adjuvant treatment and 46.8 % (n = 101) were receiving palliative treatment for metastatic disease. The rate of right and wrong perception of the chemotherapy goal was 51.9 % (n = 108) and 32.2 % (n = 67), respectively, and the rate of confused patients was 18.9 % (n = 41). The level of education was shown to be the only parameter involved in accurate perception of the treatment purpose (hazard ratio (HR) = 0.444, p = 0.025, 95 % confidence interval (CI) 0.219–0.903). In this study, there was a 51.9 % consistency between the physician’s perception and that of the patient regarding the purpose of treatment. We demonstrated that the level of education was the unique factor in accurate perception of chemotherapy goal among cancer patients.
Literature
1.
go back to reference Mack JW, Wolfe J, Grier HE et al (2006) Communication about prognosis between parents and physicians of children with cancer: parent preferences and the impact of prognostic information. J Clin Oncol 24(33):5265–5270CrossRefPubMed Mack JW, Wolfe J, Grier HE et al (2006) Communication about prognosis between parents and physicians of children with cancer: parent preferences and the impact of prognostic information. J Clin Oncol 24(33):5265–5270CrossRefPubMed
2.
go back to reference Weeks JC, Cook EF, O'Day SJ et al (1998) Relationship between cancer patients’ predictions of prognosis and their treatment preferences. JAMA 279(21):1709–1714CrossRefPubMed Weeks JC, Cook EF, O'Day SJ et al (1998) Relationship between cancer patients’ predictions of prognosis and their treatment preferences. JAMA 279(21):1709–1714CrossRefPubMed
3.
go back to reference Fried TR, Bradley EH, Towle VR et al (2002) Understanding the treatment preferences of seriously ill patients. N Engl J Med 346(14):1061–1066CrossRefPubMed Fried TR, Bradley EH, Towle VR et al (2002) Understanding the treatment preferences of seriously ill patients. N Engl J Med 346(14):1061–1066CrossRefPubMed
4.
go back to reference Rose JH, O'Toole EE, Dawson NV et al (2004) Perspectives, preferences, care practices, and outcomes among older and middle-aged patients with late-stage cancer. J Clin Oncol 22(24):4907–4917CrossRefPubMed Rose JH, O'Toole EE, Dawson NV et al (2004) Perspectives, preferences, care practices, and outcomes among older and middle-aged patients with late-stage cancer. J Clin Oncol 22(24):4907–4917CrossRefPubMed
5.
go back to reference Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67(6):361–370CrossRefPubMed Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67(6):361–370CrossRefPubMed
6.
go back to reference Aydemir Ö, Güvenir T, Küey L (1997) The hospital anxiety and depression scale Hastane anksiyete ve depresyon ölçeği: the validity and reliability of the Turkish version. Türk Psikiyatri Dergisi 8:280–287 Aydemir Ö, Güvenir T, Küey L (1997) The hospital anxiety and depression scale Hastane anksiyete ve depresyon ölçeği: the validity and reliability of the Turkish version. Türk Psikiyatri Dergisi 8:280–287
7.
go back to reference Roth AJ, Kornblith AB, Batel-Copel L et al (1998) Rapid screening for psychologic distress in men with prostate carcinoma: a pilot study. Cancer 82(10):1904–1908CrossRefPubMed Roth AJ, Kornblith AB, Batel-Copel L et al (1998) Rapid screening for psychologic distress in men with prostate carcinoma: a pilot study. Cancer 82(10):1904–1908CrossRefPubMed
8.
go back to reference National Comprehensive Cancer Network (2003) Distress management. Clinical practice guidelines. J Natl Compr Canc Netw 1(3):344–374 National Comprehensive Cancer Network (2003) Distress management. Clinical practice guidelines. J Natl Compr Canc Netw 1(3):344–374
9.
go back to reference Lennes IT, Temel JS, Hoedt C et al (2013) Predictors of newly diagnosed cancer patients’ understanding of the goals of their care at initiation of chemotherapy. Cancer 119(3):691–699CrossRefPubMedPubMedCentral Lennes IT, Temel JS, Hoedt C et al (2013) Predictors of newly diagnosed cancer patients’ understanding of the goals of their care at initiation of chemotherapy. Cancer 119(3):691–699CrossRefPubMedPubMedCentral
10.
go back to reference Temel JS, Greer JA, Admane S et al (2011) Longitudinal perceptions of prognosis and goals of therapy in patients with metastatic non-small-cell lung cancer: results of a randomized study of early palliative care. J Clin Oncol 29(17):2319–2326CrossRefPubMed Temel JS, Greer JA, Admane S et al (2011) Longitudinal perceptions of prognosis and goals of therapy in patients with metastatic non-small-cell lung cancer: results of a randomized study of early palliative care. J Clin Oncol 29(17):2319–2326CrossRefPubMed
11.
go back to reference Temel JS, Greer JA, Muzikansky A et al (2010) Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med 363(8):733–742CrossRefPubMed Temel JS, Greer JA, Muzikansky A et al (2010) Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med 363(8):733–742CrossRefPubMed
12.
go back to reference Christakis NA (2000) Death foretold: prophecy and prognosis in medical care. University of Chicago Press, Chicago Christakis NA (2000) Death foretold: prophecy and prognosis in medical care. University of Chicago Press, Chicago
13.
go back to reference Leydon GM, Boulton M, Moynihan C et al (2000) Faith, hope, and charity: an in-depth interview study of cancer patients’ information needs and information-seeking behavior. West J Med 173(1):26–31CrossRefPubMedPubMedCentral Leydon GM, Boulton M, Moynihan C et al (2000) Faith, hope, and charity: an in-depth interview study of cancer patients’ information needs and information-seeking behavior. West J Med 173(1):26–31CrossRefPubMedPubMedCentral
14.
go back to reference Jenkins V, Fallowfield L, Saul J (2001) Information needs of patients with cancer: results from a large study in UK cancer centres. Br J Cancer 84(1):48–51CrossRefPubMedPubMedCentral Jenkins V, Fallowfield L, Saul J (2001) Information needs of patients with cancer: results from a large study in UK cancer centres. Br J Cancer 84(1):48–51CrossRefPubMedPubMedCentral
15.
go back to reference Back AL, Arnold RM (2006) Discussing prognosis: “how much do you want to know?” talking to patients who are prepared for explicit information. J Clin Oncol 24(25):4209–4213CrossRefPubMed Back AL, Arnold RM (2006) Discussing prognosis: “how much do you want to know?” talking to patients who are prepared for explicit information. J Clin Oncol 24(25):4209–4213CrossRefPubMed
16.
go back to reference Delvecchio Good MJ, Good BJ et al (1990) American oncology and the discourse on hope. Cult Med Psychiatry 14(1):59–79CrossRefPubMed Delvecchio Good MJ, Good BJ et al (1990) American oncology and the discourse on hope. Cult Med Psychiatry 14(1):59–79CrossRefPubMed
17.
go back to reference Clayton JM, Butow PN, Arnold RM et al (2005) Fostering coping and nurturing hope when discussing the future with terminally ill cancer patients and their caregivers. Cancer 103(9):1965–1975CrossRefPubMed Clayton JM, Butow PN, Arnold RM et al (2005) Fostering coping and nurturing hope when discussing the future with terminally ill cancer patients and their caregivers. Cancer 103(9):1965–1975CrossRefPubMed
18.
go back to reference Christakis NA, Lamont EB (2000) Extent and determinants of error in doctors’ prognoses in terminally ill patients: prospective cohort study. BMJ 320(7233):469–472CrossRefPubMedPubMedCentral Christakis NA, Lamont EB (2000) Extent and determinants of error in doctors’ prognoses in terminally ill patients: prospective cohort study. BMJ 320(7233):469–472CrossRefPubMedPubMedCentral
19.
go back to reference Schofield PE, Butow PN, Thompson JF et al (2003) Psychological responses of patients receiving a diagnosis of cancer. Ann Oncol 14(1):48–56CrossRefPubMed Schofield PE, Butow PN, Thompson JF et al (2003) Psychological responses of patients receiving a diagnosis of cancer. Ann Oncol 14(1):48–56CrossRefPubMed
20.
go back to reference Gattellari M, Voigt KJ, Butow PN et al (2002) When the treatment goal is not cure: are cancer patients equipped to make informed decisions? J Clin Oncol 20(2):503–513CrossRefPubMed Gattellari M, Voigt KJ, Butow PN et al (2002) When the treatment goal is not cure: are cancer patients equipped to make informed decisions? J Clin Oncol 20(2):503–513CrossRefPubMed
Metadata
Title
Factors Influencing Chemotherapy Goal Perception in Newly Diagnosed Cancer Patients
Authors
Ozge Gumusay
Bulent Cetin
Mustafa Benekli
Gamze Gurcan
Mustafa N. Ilhan
Basak Bostankolu
Ahmet Ozet
Aytug Uner
Ugur Coskun
Suleyman Buyukberber
Publication date
01-06-2016
Publisher
Springer US
Published in
Journal of Cancer Education / Issue 2/2016
Print ISSN: 0885-8195
Electronic ISSN: 1543-0154
DOI
https://doi.org/10.1007/s13187-015-0827-y

Other articles of this Issue 2/2016

Journal of Cancer Education 2/2016 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine